JPMorgan Downgrades C4 Therapeutics (CCCC) to Underweight

February 24, 2023 2:19 AM

JPMorgan analyst Eric Joseph downgraded C4 Therapeutics (NASDAQ: CCCC) from Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found